Advertisement
Editorial

Drug Development for Maternal Health Cannot Be Left to the Whims of the Market

  • The PLoS Medicine Editors
  • Published: June 24, 2008
  • DOI: 10.1371/journal.pmed.0050140

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

New Medicines for Tropical Diseases in Pregnancy: Catch-22

Nicholas J White, Rose M McGready, François H Nosten
Essay | published 17 Jun 2008 | PLOS Medicine
doi:10.1371/journal.pmed.0050133

The “Other” Neglected Diseases in Global Public Health: Surgical Conditions in Sub-Saharan Africa

Doruk Ozgediz, Robert Riviello
Neglected Diseases | published 3 Jun 2008 | PLOS Medicine
doi:10.1371/journal.pmed.0050121

An Autopsy Study of Maternal Mortality in Mozambique: The Contribution of Infectious Diseases

Clara Menéndez, Cleofé Romagosa, Mamudo R Ismail, Carla Carrilho, Francisco Saute, Nafissa Osman, Fernanda Machungo, Azucena Bardaji, Llorenç Quintó, Alfredo Mayor, Denise Naniche, ...
Research Article | published 19 Feb 2008 | PLOS Medicine
doi:10.1371/journal.pmed.0050044

Market Failure and the Poverty of New Drugs in Maternal Health

Nicholas M Fisk, Rifat Atun
Policy Forum | published 22 Jan 2008 | PLOS Medicine
doi:10.1371/journal.pmed.0050022